Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.020 (1.64%)
After-hours: Dec 5, 2025, 7:36 PM EST
Bluejay Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | 0.25 | - | - | |
| Cost of Revenue | - | - | - | 0.2 | - | - | |
| Gross Profit | - | - | - | 0.05 | - | - | |
| Selling, General & Admin | 3.96 | 3.7 | 4.6 | 5.21 | 2.08 | 0.67 | |
| Research & Development | 3.01 | 3.47 | 5.71 | 4.15 | 1.15 | 0.53 | |
| Operating Expenses | 6.98 | 7.17 | 10.31 | 9.37 | 3.23 | 1.2 | |
| Operating Income | -6.98 | -7.17 | -10.31 | -9.32 | -3.23 | -1.2 | |
| Interest Expense | -0 | -0.82 | - | - | -0.51 | -0.14 | |
| Interest & Investment Income | 0.1 | 0.15 | 0.16 | 0.09 | - | - | |
| Other Non Operating Income (Expenses) | 0.02 | 0.13 | 0.19 | 0.17 | 0.25 | 0.08 | |
| EBT Excluding Unusual Items | -6.85 | -7.72 | -9.95 | -9.06 | -3.49 | -1.26 | |
| Asset Writedown | - | - | - | -0.24 | - | - | |
| Other Unusual Items | - | - | - | - | 0.01 | 0.1 | |
| Pretax Income | -6.85 | -7.72 | -9.95 | -9.3 | -3.49 | -1.16 | |
| Net Income | -6.85 | -7.72 | -9.95 | -9.3 | -3.49 | -1.16 | |
| Preferred Dividends & Other Adjustments | - | 13.22 | - | - | - | - | |
| Net Income to Common | -6.85 | -20.94 | -9.95 | -9.3 | -3.49 | -1.16 | |
| Shares Outstanding (Basic) | 1 | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | - | - | - | - | |
| EPS (Basic) | -6.78 | -114.19 | - | - | - | - | |
| EPS (Diluted) | -6.78 | -114.19 | - | - | - | - | |
| Free Cash Flow | -6.05 | -8.13 | -9.02 | -8.94 | -4.39 | -0.51 | |
| Free Cash Flow Per Share | -5.99 | -44.31 | - | - | - | - | |
| Gross Margin | - | - | - | 19.64% | - | - | |
| Operating Margin | - | - | - | -3741.48% | - | - | |
| Profit Margin | - | - | - | -3733.11% | - | - | |
| Free Cash Flow Margin | - | - | - | -3590.13% | - | - | |
| EBITDA | -6.91 | -7.09 | -9.66 | -9.16 | -3.08 | -1.04 | |
| D&A For EBITDA | 0.07 | 0.08 | 0.65 | 0.16 | 0.15 | 0.16 | |
| EBIT | -6.98 | -7.17 | -10.31 | -9.32 | -3.23 | -1.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.